コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ythroid progenitors and eventually promoting erythroleukemia.
2 t to the development of Friend virus-induced erythroleukemia.
3 e for the resistance to Friend virus-induced erythroleukemia.
4 r the constitutively activated mutant caused erythroleukemia.
5 with GATA1 function, thereby contributing to erythroleukemia.
6 irus in check and developed fatal FV-induced erythroleukemia.
7 dysregulation of PU.1 expression can lead to erythroleukemia.
8 o directly address the role of p53 in Friend erythroleukemia.
9 y also have possible therapeutic utility for erythroleukemia.
10 ration of erythroid progenitors and inducing erythroleukemia.
11 also be a useful marker for the diagnosis of erythroleukemia.
12 ensued, most commonly lymphoid leukemia and erythroleukemia.
13 of the Moloney virus from T-cell leukemia to erythroleukemia.
14 d to the erythroid lineage, and induction of erythroleukemia.
15 xplanation of v-ErbA activity in AEV-induced erythroleukemia.
16 trongly associated with Friend virus-induced erythroleukemia.
17 ring the progression of Friend-virus-induced erythroleukemia.
18 forming virus (SFFV) results in a multistage erythroleukemia.
19 F1IP and MLF1 deregulation in the genesis of erythroleukemias.
20 globin but not beta-globin; transgenic mouse erythroleukemia 585 cells express predominantly human be
22 actor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize o
23 those from mice susceptible to SFFV-induced erythroleukemia also express a short form of the recepto
24 ll mice exhibited accelerated progression to erythroleukemia and accelerated death following diagnosi
25 elated factor 2 (Nrf2) pathway in K562 human erythroleukemia and other cell types after treatment wit
26 ith AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leuk
29 e exhibit decreased susceptibility to Friend erythroleukemia and that expansion of erythroid progenit
30 utes to both early and late stages of Friend erythroleukemia and that persistence of F-gp55 expressio
31 etion in Gab2 are less susceptible to Friend erythroleukemia and the expansion of erythroid progenito
32 s are >/= 20%, the disorder is classified as erythroleukemia, and when BM blasts are < 20%, as myelod
34 ne leukemia virus (F-MuLV) in F-MuLV induced erythroleukemia, as well as that of the 10A1 and Graffi
35 ression may be required not only to initiate erythroleukemia but to also maintain erythroleukemia fol
36 ce does not independently prevent FV-induced erythroleukemia but works in concert with the immune sys
42 ctivation function, we cotransfected a human erythroleukemia cell line (K562) with a locus control re
44 amma-globin promoter complexes in K562 human erythroleukemia cell line and primary human fetal and ad
46 This segment can be excised from an avian erythroleukemia cell line by restriction enzyme digestio
47 These segments were excised from an avian erythroleukemia cell line by restriction enzyme digestio
50 ylation of sf-Stk can also be detected in an erythroleukemia cell line derived from an SFFV-infected
53 livery of this transcription factor into the erythroleukemia cell line K562 resulted in an increase o
56 on to a 2-D gel separation of the same human erythroleukemia cell line lysate, the IEF-NP RP HPLC pro
57 inal erythroid differentiation of the murine erythroleukemia cell line MEL, whereas its overexpressio
58 screening, and lack of functional effects in erythroleukemia cell line TF-1 and CD34(+) progenitor ce
60 btraction cDNA library approach from a mouse erythroleukemia cell line that had been induced to polyp
61 detected in cells of the K562 line, a human erythroleukemia cell line, and in CD34+ primary human he
67 In contrast, studies with the K562 human erythroleukemia cell line, which is often used for compa
71 ulation of PU.1 transcription in established erythroleukemia cell lines differed depending upon the l
72 ocytes from Friend SFFV-infected mice and in erythroleukemia cell lines from Friend MuLV-infected mic
73 ed mice but did not alter AP1 DNA binding in erythroleukemia cell lines from Friend SFFV-infected mic
77 n erythrocyte membranes and from K562 (human erythroleukemia) cell membranes, has robust peptidylprol
79 in undifferentiated and differentiated human erythroleukemia cells (HEL) using SEEL using the sialylt
81 surface coreceptor for entry, we used human erythroleukemia cells (K562), which allow parvovirus B19
83 lyzed the responses of HeLa cells and murine erythroleukemia cells (MELC) to hexamethylene bisacetami
85 We have purified an mSin3A complex from K562 erythroleukemia cells and identified three new mSin3A-as
87 s, into a defined chromosomal site in murine erythroleukemia cells and monitored the stability of the
88 using DNA-protein binding studies and human erythroleukemia cells and promoter activity using lucife
89 close to 100 % of negatively selected mouse erythroleukemia cells and ranges from 10 to 50 % in embr
90 of CR2 were expressed on the surface of K562 erythroleukemia cells and their binding ability assessed
91 CReP was also required for exocytosis from erythroleukemia cells and thus appears to play a broader
92 Attachment of B. burgdorferi N40 to human erythroleukemia cells and to human saphenous vein endoth
93 ogenous enzyme or cocultured with human K562 erythroleukemia cells as an exogenous source of TPI.
96 n of megakaryocytic differentiation of human erythroleukemia cells by 12-O-tetradecanoylphorbol-13-ac
97 er transfer of gamma globin genes into mouse erythroleukemia cells can be used for the analysis of re
98 To address this issue, we used hybrid murine erythroleukemia cells containing a single copy of human
100 d (65)Zn uptake activity in transfected K562 erythroleukemia cells expressing hZip2 from the CMV prom
101 ude that two independent pathways operate in erythroleukemia cells for nitric oxide-mediated protecti
102 Recombinant OPN and BSP can protect murine erythroleukemia cells from attack by human complement as
103 In our preliminary study, we found that K562 erythroleukemia cells have an extremely low level of end
106 onstructs transfected into NIH 3T3 and mouse erythroleukemia cells indicated that the housekeeping pr
107 cetylation increased significantly in murine erythroleukemia cells induced to differentiate in cultur
108 ADNP or ADNP2 in zebrafish embryos or mouse erythroleukemia cells inhibited erythroid maturation, wi
109 -globin gene expression is evident in murine erythroleukemia cells lacking the p45 subunit of NF-E2.
112 e expression of the -90 beta-ZF-DBD in mouse erythroleukemia cells reduced the binding of KLF1 with t
113 d chemosensitization was observed on K562/R7 erythroleukemia cells resistant to doxorubicin, especial
114 rgeted introduction of this allele into K562 erythroleukemia cells results in a proliferation defect
118 TNF-alpha expression in the proliferation of erythroleukemia cells that is distinct from the effect o
119 nous Sias on transfected cells, and by using erythroleukemia cells to allow experimental manipulation
120 talin synthesis enhances sensitivity of K562 erythroleukemia cells to CDC, whereas overexpression of
121 study, we used nuclear extracts from murine erythroleukemia cells to purify a protein complex that b
122 hese compounds also induced HL-60 and murine erythroleukemia cells to undergo partial differentiation
123 have now analyzed laminin binding to murine erythroleukemia cells transfected with various human B-C
126 ntegration into three defined loci in murine erythroleukemia cells using recombinase-mediated cassett
127 st extracellular loop of the P2Y(2)R to K562 erythroleukemia cells was inhibited by antibodies agains
130 megakaryocytes (and megakaryocyte-like human erythroleukemia cells), a regulatory role in cellular de
133 activated K+ channels of human erythrocytes, erythroleukemia cells, and ferret vascular smooth muscle
134 gulatory protein 2, in iron-deficient murine erythroleukemia cells, and in human patients with ISCU m
135 tial for erythroid differentiation of murine erythroleukemia cells, and serine/threonine phosphorylat
136 e mRNA was unchanged in iron-depleted murine erythroleukemia cells, and the stability of mature ferro
137 3 accelerates differentiation of both murine erythroleukemia cells, as well as fetal liver cells, whe
139 thyl sulfoxide treatment of wild-type murine erythroleukemia cells, but not a mutant clone of dimethy
140 to the LCR occurs in undifferentiated murine erythroleukemia cells, but phosphorylation of LCR-associ
141 syngeneic fully autochthonous system (FBL-3 erythroleukemia cells, C57BL/6 mice, and highly purified
142 cytosine methyltransferase isoform in mouse erythroleukemia cells, Dnmt1, exhibits potent dead-end i
143 e assessed in stable transfectants of murine erythroleukemia cells, in which the activities of cyclin
144 on and reduced with RUNX1 knockdown in human erythroleukemia cells, indicating that PCTP is regulated
145 is required for beta-globin transcription in erythroleukemia cells, induces histone H3 hyperacetylati
147 also p53 mutants, such as p53 M133K in human erythroleukemia cells, leading to pathologic gene expres
148 In luciferase reporter studies in human erythroleukemia cells, mutation of each site decreased a
150 3-integrin gene transcription in human K-562 erythroleukemia cells, Raf activation in NIH 3T3 cells l
151 in vitro erythroid differentiation in murine erythroleukemia cells, resulting in phenotypical cross-c
155 ) cDNA transfected into HeLa cells and mouse erythroleukemia cells, where it was expressed in the con
191 ospho-STAT5; (iii) induce apoptosis in human erythroleukemia cells; and (iv) suppress pathologic cell
192 ith 10% to < 20% BM blasts from TNCs fulfill erythroleukemia criteria; however, by considering blasts
193 single-cell clones derived from HFV-infected erythroleukemia-derived cells (H92), there were up to 20
197 in vivo progression of Friend virus-induced erythroleukemia has been suggested but not clearly defin
201 -myristate 13-acetate (PMA)-stimulated human erythroleukemia (HEL) and CHRF 288-11 cells, which have
202 ed regulation of the serglycin gene in human erythroleukemia (HEL) and CHRF 288-11 cells, which have
203 iferation of the Jak2-V617F expressing human erythroleukemia (HEL) cell line by promoting marked cell
205 he cellular action of NO, we inhibited human erythroleukemia (HEL) cell-surface PDI expression using
207 ivation of endogenous alphaIIbbeta3 in human erythroleukemia (HEL) cells and beta1 integrin activatio
209 d in bipotential human cells (K562 and human erythroleukemia (HEL) cells), proerythroblastic mouse (M
210 Here, we used human platelets and human erythroleukemia (HEL) cells, which express integrin alph
213 s of the cultured JAK2V617F-expressing human erythroleukemia HEL92.1.7 and Ba/F3-JAK2V617F cells.
214 lobin locus in a human fetal liver and mouse erythroleukemia hybrid cell (A181gamma cell) that contai
217 leen focus-forming virus (SFFV) causes rapid erythroleukemia in mice due to expression of its unique
218 Friend virus induces the development of erythroleukemia in mice through the interaction of a vir
219 ng the initial stage of Friend virus-induced erythroleukemia in mice, interaction of the viral protei
222 disease is essential for the progression of erythroleukemia in the presence of differentiation signa
228 we replaced the U3 region of the LTR of the erythroleukemia-inducing Friend murine leukemia virus (F
236 )-induced cytotoxicity in a subline of human erythroleukemia K562 cells (K/VP.5) and in K/VP.5 cells
239 oduction was induced by glutamate, and human erythroleukemia K562 cells in which H(2)O(2) production
240 rmore, we detected the 2.8-kb PDGF-B mRNA in erythroleukemia K562 cells upon 12-O-tetradecanoylphorbo
241 arabine (Ara C)-dependent differentiation of erythroleukemia K562 cells, we observed effects that ind
243 , ZFP161) and measure reporter expression in erythroleukemia (K562) and liver carcinoma (HepG2) cell
244 of LEF to induce differentiation of a human erythroleukemia (K562) cell line and show that LEF induc
248 TfR2-alpha mRNA were significantly higher in erythroleukemia (M6) marrow samples than in nonmalignant
249 leukemia, suggesting that a key mechanism in erythroleukemia may be the collaboration of lesions dist
250 (SF2/ASF) expression in differentiated mouse erythroleukemia mediates a differentiation stage-specifi
253 Herein we have derived stable Friend mouse erythroleukemia (MEL) cell clones expressing either Mfrn
257 NF-related complex (PYR complex) from murine erythroleukemia (MEL) cell nuclear extract that binds py
258 ide (HMBA)-induced differentiation of murine erythroleukemia (MEL) cells and blocked differentiation;
259 y pathway is recapitulated in cultured mouse erythroleukemia (MEL) cells and targets nonsense-free mR
262 ide (DMSO)-induced differentiation of murine erythroleukemia (MEL) cells as a model, transcription of
263 uring erythrocytic differentiation of murine erythroleukemia (MEL) cells induced by dimethylsulfoxide
264 nditional expression of C/EBPalpha in murine erythroleukemia (MEL) cells induced myeloid-specific gen
265 recipitate with Tal1 in extracts from murine erythroleukemia (MEL) cells induced to differentiate wit
268 ion of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the le
269 ell lines, whereas A-kinase-deficient murine erythroleukemia (MEL) cells show impaired hemoglobin pro
270 in dynamics to the differentiation of murine erythroleukemia (MEL) cells, a model system for erythroi
271 ary conservation was established using mouse erythroleukemia (MEL) cells, a well studied erythropoies
272 ce adult erythroid differentiation in murine erythroleukemia (MEL) cells, but only SCFAs concurrently
273 er enhancement than the intact core in mouse erythroleukemia (MEL) cells, indicating the presence of
289 d mechanistic studies in the TF-1 IDH2 R140Q erythroleukemia model system and found that IDH2 mutant
290 which spontaneously recover from FV-induced erythroleukemia, neutralization of gamma interferon (IFN
291 n insertion in SB-induced JAK2V617F-positive erythroleukemias, present in 87.5% and 65%, respectively
293 ious data demonstrating a role for MLF1IP in erythroleukemias, suggest a possible function for this p
297 elta(12)-PGJ(3) to mice infected with Friend erythroleukemia virus or those expressing the chronic my
298 ivation in another cell line-Rauscher murine erythroleukemia- which expresses the EPO receptor endoge
299 his disease had the overall appearance of an erythroleukemia, with an accumulation of immature erythr
300 jected into adult mice, SFFV induces a rapid erythroleukemia, with susceptibility being determined by
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。